General Information of Drug Formulation (ID: F02005)

Formulation Name
Atorvastatin 20 mg tablet
Company
Cambridge Therapeutics Technologies; Sandoz
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carboxymethylcellulose sodium E00621 Not Available Adsorbent; Binding agent; Disintegrant; Emulsifying agent; Suspending agent; Viscosity-controlling agent
Ferric hydroxide oxide yellow E00539 23320441 Colorant
Glycerin E00026 753 Antimicrobial preservative; Emollient; Flavoring agent; Humectant; Lubricant; Plasticizing agent; Solvent; Suppository base; Tonicity agent; Viscosity-controlling agent
Magnesium stearate E00208 11177 lubricant
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Tromethamine E00125 6503 Alkalizing agent; Buffering agent; Emulsifying agent